Archives

Centivax: $45 Million Series A Raised For Advancing Universal Flu Vaccine

By Amit Chowdhry ● Jul 10, 2025

Centivax, a biotech firm developing vaccines and therapies for long-lasting, universal protection against diverse targets, announced it has closed an oversubscribed $45 million Series A funding round. Steve Jurvetson of Future Ventures led the round. Investors also included NFX, BOLD Capital Partners, Base4 Capital, Kendall Capital Partners, Amplify Partners, and more. Existing insiders increased their stakes.

FireMon: Interview With CMO Alex Bender About The Security Operations Company

By Amit Chowdhry ● Jul 10, 2025

FireMon is a company on a mission to improve security operations that will, in turn, lead to better security outcomes. Pulse 2.0 interviewed FireMon CMO Alex Bender to gain a deeper understanding of the company.

Cyberstarts: $300 Million Employee Liquidity Fund Launched

By Amit Chowdhry ● Jul 10, 2025

Cyberstarts, a leading early-stage cybersecurity venture firm, has launched a $300 million Employee Liquidity Fund to reward startup employees and boost momentum in its portfolio companies.

ConnectSecure: Interview With CEO Peter Bellini On Evolving Vulnerability Management For MSPs

By Amit Chowdhry ● Jul 10, 2025

ConnectSecure empowers information security professionals and MSPs to safeguard their business-critical data from vulnerabilities and exploits. Pulse 2.0 interviewed ConnectSecure CEO Peter Bellini to gain a deeper understanding of the company.

Theo Ai: Interview With Legal Product Lead Sarah Johansson About The Legal Prediction Engine

By Amit Chowdhry ● Jul 10, 2025

Theo Ai is a company that is creating the world's most accurate legal prediction engine to forecast the outcome of legal disputes. Pulse 2.0 interviewed Theo Ai Legal Product Lead Sarah Johansson to gain a deeper understanding of the company.

LLCP: Fund VII Closed At Over $3.6 Billion

By Amit Chowdhry ● Jul 10, 2025

Levine Leichtman Capital Partners (LLCP), a Los Angeles-based private equity firm, has closed LLCP Fund VII with capital commitments exceeding $3.6 billion, surpassing its target. The fund received strong support from both existing and new institutional investors, even in a challenging fundraising environment.

ALTR: $5 Million Seed Raised For Alcohol Removal Technology

By Amit Chowdhry ● Jul 10, 2025

ALTR, a beverage technology company, has raised $5 million in seed funding to commercialize its innovative alcohol removal technology. Its proprietary "Flavor-First" process creates premium low-alcohol drinks that maintain a whole sensory experience. The funding round was led by French investment fund Demeter, with participation from Suntory Global Spirits, Techmind, AZ Venture Capital Inc., FTW Ventures, Bluestein Ventures, Solvable, and Xinomavro.

Actithera: $75.5 Million Series A Raised For Transforming Precision Radioligand Therapy

By Amit Chowdhry ● Jul 10, 2025

Actithera, a biotech company specializing in radiopharmaceuticals, has secured $75.5 million in an oversubscribed Series A financing round. This funding will help advance their lead FAP (Fibroblast Activation Protein) asset into clinical development and support the growth of their proprietary radioligand therapy (RLT) discovery platform.